The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent expirations of the key blockbuster revenue generating drugs such as Cymbalta (duloxetine) of Eli Lilly & Co. and Lyrica (pregabalin) of Pfizer, Inc. This report studies the global market for pain management therapeutics from three perspectives - therapeutic classes of drugs, indications and geography. Each of these segments is further classified into sub-segments; therapeutic classes include anticonvulsants, antidepressants, anesthetics, NSAIDs, opioids, anti-migraine agents and other non-narcotic analgesics. View Full Report With TOC @ http://www.researchmoz.us/pain-management-therapeutics-market-global-industry-size-share-trends-analysis-and-forecast-2012-2018-report.html

1. Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids,
Other Non-Narcotic Analgesics and Anti-Migraine Agents) - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast, 2012 - 2018
The global pain management therapeutics market is expected to witness a decline during the forecast period
(2012 to 2018) due to patent expirations of the key blockbuster revenue generating drugs such as Cymbalta
(duloxetine) of Eli Lilly & Co. and Lyrica (pregabalin) of Pfizer, Inc. This report studies the global market for
pain management therapeutics from three perspectives - therapeutic classes of drugs, indications and
geography. Each of these segments is further classified into sub-segments; therapeutic classes include
anticonvulsants, antidepressants, anesthetics, NSAIDs, opioids, anti-migraine agents and other non-narcotic
analgesics.
The various pain management indications studied in this report include neuropathic pain, fibromyalgia,
arthritic pain, chronic back pain, migraine, post-operative pain and cancer pain. Market sizes and forecasts for
the period 2010 – 2018 have been provided for each of the segments and sub-segments in terms of
USD million, considering 2011 as the base year. The % compound annual growth rate (CAGR) for each
market segment for the forecast period (2012 to 2018) has been provided along with market size estimations.
Geographically, the market has been segmented into four regions, namely, North America, Europe,
Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for
each of these regions along with the CAGR. The market overview section of the report provides a detailed
breakdown of various aspects of market dynamics such as drivers, restraints and opportunities along with
market attractiveness analysis and Porter’s five force analysis for the pain management therapeutics
market.
The competitive landscape section includes market share analysis of all the leading players in the branded
pharmaceuticals market for pain management, in terms of percentage share in the year 2011. Some of the
major players profiled in this report include Abbott Laboratories, Inc., AstraZeneca PLC, Eli Lilly & Co.,
Endo Health Solutions, Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc. and Purdue Pharma LP.
The global pain management market is segmented into the following categories:
Pain Management Therapeutics Market, by Therapeutic Class Anticonvulsants Antidepressants Anesthetics
NSAIDs Opioids Other Non-Narcotic Analgesics (Acetaminophen) Anti-Migraine Agents
Pain Management Therapeutics Market, by Indication Neuropathic Pain Fibromyalgia Arthritic Pain, by
Type Osteoarthritis Rheumatoid Arthritis Chronic Back Pain Migraine Post-operative Pain Cancer Pain
Pain Management Therapeutics Market, by Geography North America Europe Asia-Pacific Rest of the
World (RoW)
table Of Content
chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics an

2. chapter 2 Executive Summary
chapter 3 Market Overview
3.1 Introduction To Pain Management – Types Of Treatments
3.2 World Health Organization’s “pain Ladder” For Cancer
3.3 Market Trends And Future Outlook
3.3.1 Impact Of Generics
3.3.2 Key Patent Expirations
3.4 Market Drivers
3.4.1 Global Increasing Incidence Of Chronic Pain Disorders
3.4.2 Favorable Regulatory Scenario And Healthcare Reforms
3.4.3 Easy And Effective Medications
3.4.4 Impact Analysis Of Market Drivers
3.5 Market Restraints
3.5.1 Prescription Drug Abuse
3.5.2 Pain Advocacy Groups Losing Power, Influence And Funding
3.5.3 Adulteration And Fake Drugs Thrive In Developing Regions
3.5.4 Long Term Pain Relief From Surgical Procedures, Alternative Therapies And Medical Devices
3.5.5 Impact Analysis Of Market Restraints
3.6 Market Opportunities
3.6.1 Novel Molecule Combinations And Drug Delivery Techniques Are Expected To Become A Rising
Opportunity In Forecast Period
3.6.2 Generics Expected To Be A Rising Opportunity Globally
3.7 Porter’s Five Forces Analysis
3.7.1 Bargaining Power Of Buyers
3.7.2 Bargaining Power Of Suppliers
3.7.3 Threat Of Substitutes
3.7.4 Threat Of New Entrants
3.7.5 Competitive Rivalry
3.8 Market Attractiveness Analysis: Global Pain Management Therapeutics Market, By Geography (2011)
chapter 4 Global Pain Management Therapeutics Market, By Therapeutic Class
4.1 Anticonvulsants
4.1.1 Current And Future Market Scenario
4.2 Antidepressants
4.2.1 Current Market Scenario And Patent Expiry Effect
4.2.2 Future Market Scenario
4.3 Anesthetics
4.3.1 Current Market Scenario And Patent Expiry Effect
Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics an

3. 4.3.2 Pipeline Drugs And Their Effect
4.3.3 General Anesthetics
4.3.4 Local Anesthetics
4.4 Non-steroidal Anti-inflammatory Drugs (nsaids)
4.4.1 Current Market Scenario And Patent Expiry Effect
4.5 Opioids
4.5.1 Current Market Scenario And Patent Expiry Effect
4.5.2 Pipeline Drugs And Their Effect On The Market
4.5.2.1 Moxduo Ir
4.5.2.2 Remoxy
4.6 Anti-migraine Agents
4.6.1 Pipeline Drugs And Additional Approvals
4.7 Other Non-narcotic Analgesics (acetaminophen)
chapter 5 Global Pain Management Therapeutics Market, By Indication
5.1 Neuropathic Pain
5.2 Fibromyalgia
5.3 Arthritic Pain
5.3.1 Osteoarthritis (oa)
5.3.2 Rheumatoid Arthritis (ra)
5.4 Chronic Back Pain
5.5 Migraine
5.6 Post-operative Pain
5.7 Cancer Pain
chapter 6 Global Pain Management Therapeutics Market, By Geography
6.1 Overview
6.1.1 Global Pain Management Therapeutics Market, By Geography, Size And Forecast, 2010 – 2018
(usd Million)
6.1.2 Comparative Analysis: Global Pain Management Therapeutics Market, By Geography, 2011 & 2018
(value %)
6.2 North America
6.2.1 North America Pain Management Therapeutics market, By Therapeutic Class, Size And Forecast, 2010
- 2018 (usd Million)
6.3 Europe
6.3.1 Europe Pain Management Therapeutics market, By Therapeutic Class, Size And Forecast, 2010 - 2018
(usd Million)
6.4 Asia-pacific
6.4.1 Asia-pacific Pain Management Therapeutics market, By Therapeutic Class, Size And Forecast, 2010 -
2018 (usd Million)
6.5 Rest Of The World (row)
Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics an

4. 6.5.1 Row Pain Management Therapeutics Market, By Therapeutic Class, Size And
forecast, 2010 - 2018 (usd Million)
chapter 7 Competitive Landscape
7.1 Market Share Analysis: Global Pain Management Therapeutics Market (2011)
7.1.1 Market Share By Marketing Status (branded & Generic Pharmaceuticals), 2011 (%)
7.1.2 Market Share By Key Players: Branded Pharmaceuticals, 2011 (%)
7.2 Pipeline Snapshot: Pain Management Therapeutics
7.2.1 Moxduo (morphine And Oxycodone)
7.2.2 Remoxy (oxycodone)
7.2.3 Posidur (saber-bupivacaine)
7.2.4 Zecuity (transdermal Sumatriptan)
chapter 8 Recommendations
8.1 Development Of Novel Combination Formulations
8.2 Addressing Unmet Needs: Drug Abuse And Side-effects
8.3 Generics Manufacturers: Investment In Emerging Markets Such As India, China And Russia
8.4 Mergers And Acquisitions To Enter Or Strengthen Market Presence
chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Allergan, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Covidien Plc
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Durect Corporation
9.4.1 Company Overview
Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics an

5. 9.4.2 Financial Overview
9.4.3 Pipeline Products
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Eli Lilly And Company
9.5.1 Business Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Endo Health Solutions, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Forest Laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Glaxosmithkline Plc
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Hospira, Inc.
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Johnson & Johnson
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Merck & Co., Inc.
9.11.1 Company Overview
9.11.2 Financial Overview
Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics an

6. 9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Mundipharma International Ltd.
9.12.1 Company Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Novartis international Ag
9.13.1 Company Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.13.5 Recent Developments
9.14 Nupathe, Inc.
9.14.1 Company Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments
9.15 Pain Therapeutics, Inc.
9.15.1 Company Overview
9.15.2 Financial Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies
9.15.5 Recent Developments
9.16 Pfizer, Inc.
9.16.1 Company Overview
9.16.2 Financial Overview
9.16.3 Product Portfolio
9.16.4 Business Strategies
9.16.5 Recent Developments
9.17 Purdue Pharma L.p.
9.17.1 Company Overview
9.17.2 Financial Overview
9.17.3 Product Portfolio
9.17.4 Business Strategies
9.17.5 Recent Developments
9.18 Qrx Pharma Ltd.
9.18.1 Company Overview
9.18.2 Financial Overview
9.18.3 Product Portfolio
Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics an

7. 9.18.4 Business Strategies
9.18.5 Recent Developments
9.19 Sanofi
9.19.1 Company Overview
9.19.2 Financial Overview
9.19.3 Product Portfolio
9.19.4 Business Strategies
9.19.5 Recent Developments
9.20 Teva Pharmaceutical Industries Limited
9.20.1 Company Overview
9.20.2 Financial Overview
9.20.3 Product Portfolio
9.20.4 Business Strategies
9.20.5 Recent Developments
9.21 Ucb (union Chemnique Belge) S.a.
9.21.1 Company Overview
9.21.2 Financial Overview
9.21.3 Product Portfolio
9.21.4 Business Strategies
9.21.5 Recent Developments
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics an